ChemicalBook > Product Catalog > Analytical Chemistry > Standard > Pharmaceutical Impurity Reference Standards > 2-CHLORO-N-(2,5-DIMETHYLPHENYL)ACETAMIDE
2-CHLORO-N-(2,5-DIMETHYLPHENYL)ACETAMIDE
2-CHLORO-N-(2,5-DIMETHYLPHENYL)ACETAMIDE Basic information
- Product Name:
- 2-CHLORO-N-(2,5-DIMETHYLPHENYL)ACETAMIDE
- Synonyms:
-
- JR-8651, 2-Chloro-N-(2,5-dimethylphenyl)acetamide, 97%
- Lidocaine impurity 22/2-Chloro-N-(2,5-dimethylphenyl)acetamide
- Acetamide, 2-chloro-N-(2,5-dimethylphenyl)-
- Lidocaine-015
- Lidocaine Impurity 18
- ART-CHEM-BB B015632
- CHEMBRDG-BB 3015632
- 2-CHLORO-N-(2,5-DIMETHYLPHENYL)ACETAMIDE
- CAS:
- 5177-35-5
- MF:
- C10H12ClNO
- MW:
- 197.66
- Mol File:
- 5177-35-5.mol
More
Less
2-CHLORO-N-(2,5-DIMETHYLPHENYL)ACETAMIDE Chemical Properties
- Melting point:
- 151 °C
- Boiling point:
- 326.8±30.0 °C(Predicted)
- Density
- 1.187±0.06 g/cm3(Predicted)
- solubility
- DCM, Methanol
- form
- Solid
- pka
- 12.91±0.70(Predicted)
- color
- Off-White
More
Less
Safety Information
- Hazard Codes
- Xi
- HazardClass
- IRRITANT
More
Less
2-CHLORO-N-(2,5-DIMETHYLPHENYL)ACETAMIDESupplier
J & K SCIENTIFIC LTD.
- Tel
- 010-82848833 400-666-7788
- jkinfo@jkchemical.com
Chemsky(shanghai)International Co.,Ltd.
- Tel
- 021-50135380
- shchemsky@sina.com
ChemStrong Scientific Co.,Ltd
- Tel
- 0755-0755-66853366 13670046396
- sales@chem-strong.com
Mashilabs (Shanghai) Co.,Ltd.
- Tel
- 19916721580
- mafarm@126.com
Jiangsu Aikon Biopharmaceutical R&D co.,Ltd.
- Tel
- 025-66113011 18112977050
- cb6@aikonchem.com
More
Less
2-CHLORO-N-(2,5-DIMETHYLPHENYL)ACETAMIDE(5177-35-5)Related Product Information
- Chloro-N-(2,4-dimethylphenyl)acetamide
- N-Methyl-N-((3S,4S)-4-Methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyriMidin-4-aMine
- Tofacitinib Impurity 2
- Tofacitinib Impurity 45
- Tofacitinib Related Compound
- 1-BENZYL-N,4-DIMETHYLPIPERIDIN-3-AMINE DIHYDROCHLORIDE
- (3S,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine
- N-(2,6-dimethylphenyl)-2-((2,6-dimethylphenyl)amino)acetamide
- 3-PiperidinaMine, 1-acetyl-N,4-diMethyl-N-1H-pyrrolo[2,3-d]pyriMidin-4-yl-, (3R,4R)- (9CI)
- butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate
- Tofacitinib Impurity
- N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
- 3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile
- 3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide
- 1-Piperidinepropanoic acid, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, ethyl ester, (3R,4R)-
- 7H-Pyrrolo[2,3-d]pyriMidin-4-aMine, N-Methyl-N-[(3R,4R)-4-Methyl-1-(phenylMethyl)-3-piperidinyl]-7-[(4-Met hylphenyl)sulfonyl]-
- 6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine
- Tofacitinib Impurity 36